Immuneering schedules call to discuss pancreatic cancer trial data
Tweet Send to a Friend
Immuneering Corporation (NASDAQ: IMRX) will host a conference call on September 29, 2025, at 8:30 a.m. ET to discuss updated ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
